ZLD — Zelira Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$8.06m
- AU$10.07m
- AU$0.55m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -2.08 | -3.51 | -1.63 | -1.09 | -0.757 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.34 | -6.94 | -8.62 | -9.43 | -7.25 |
Capital Expenditures | -0.028 | -0.016 | 0 | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.76 | 1.12 | 1.38 | -0.208 | 2.83 |
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.732 | 1.11 | 1.38 | -0.208 | 2.83 |
Financing Cash Flow Items | — | -0.287 | -0.088 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 4.5 | 10.5 | 7.1 | 1.77 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.61 | -1.38 | 3.27 | -2.22 | -2.6 |